{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T02:15:51Z","timestamp":1694830551953},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.transci.2013.07.007","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T03:45:43Z","timestamp":1375674343000},"page":"640-643","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Era of blood component therapy: Time for mandatory pre-donation platelet count for maximizing donor safety and optimizing quality of platelets"],"prefix":"10.1016","volume":"49","author":[{"given":"Sudipta Sekhar","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.U.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipak","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2013.07.007_b0005","series-title":"Drugs & Cosmetics Act","author":"Malik","year":"2001"},{"key":"10.1016\/j.transci.2013.07.007_b0010","unstructured":"Council of Europe. Guide to the preparation, use and quality assurance of blood components. 4th ed. Germany; 1998."},{"key":"10.1016\/j.transci.2013.07.007_b0015","series-title":"Technical manual","author":"Brecher","year":"2005"},{"key":"10.1016\/j.transci.2013.07.007_b0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3324\/haematol.2010.029934","article-title":"Analysis of 12,517 inhabitants of a Sardinian geographic isolate reveals that predispositions to thrombocytopenia and thrombocytosis are inherited traits","volume":"96","author":"Biino","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2013.07.007_b0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.annepidem.2005.06.052","article-title":"Platelet counts differ by sex, ethnicity, and age in the United States","volume":"16","author":"Segal","year":"2006","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.transci.2013.07.007_b0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/s-0037-1613840","article-title":"A novel approach to the assessment of variations in the human platelet count","volume":"83","author":"Buckley","year":"2000","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.transci.2013.07.007_b0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1098-1101(1998)13:3<114::AID-JCA4>3.0.CO;2-6","article-title":"Apheresis platelets: emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose","volume":"13","author":"Goodnough","year":"1998","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.transci.2013.07.007_b0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1423-0410.1999.7610043.x","article-title":"Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy","volume":"76","author":"Goodnough","year":"1999","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2013.07.007_b0045","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2257.2005.00714.x","article-title":"Factors influencing yield of plateletpheresis using intermittent flow cell separator","volume":"27","author":"Das","year":"2005","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.transci.2013.07.007_b0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0973-6247.53882","article-title":"Quality assessment of platelet concentrates prepared by platelet rich plasma\u2013platelet concentrate, buffy coat poor\u2013platelet concentrate (BC\u2013PC) and apheresis-PC methods","volume":"3","author":"Singh","year":"2009","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.transci.2013.07.007_b0055","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1537-2995.1990.30790385523.x","article-title":"Platelet activation during preparation of platelet concentrate: a comparison of platelet rich plasma and the buffy coat methods","volume":"30","author":"Fijnheer","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2013.07.007_b0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1537-2995.1988.28388219156.x","article-title":"Preparation of white cell poor blood components using a quadruple bag system","volume":"28","author":"Hirosue","year":"1988","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2013.07.007_b0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1537-2995.1992.32292180138.x","article-title":"Paired comparison of platelet concentrates prepared from platelet rich plasma and buff y coats using a new technique with 111In and 51Cr","volume":"32","author":"Keegan","year":"1992","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2013.07.007_b0070","first-page":"188","article-title":"Pre- and post- donation hematological values in healthy donors undergoing plateletpheresis with five different systems","volume":"7","author":"Das","year":"2009","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2013.07.007_b0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0188-4409(02)00453-8","article-title":"Hemoglobin and platelet count effect on platelet yields in plateletpheresis","volume":"34","author":"Guerrero-Rivera","year":"2003","journal-title":"Arch Med Res"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213002346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213002346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T10:25:23Z","timestamp":1563618323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050213002346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1473050213002346"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2013.07.007","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Era of blood component therapy: Time for mandatory pre-donation platelet count for maximizing donor safety and optimizing quality of platelets","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2013.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}